Table of Contents page: European Journal of Cancer

Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

A first-in-human phase I study of SAR125844, a selective MET tyrosine kinase inhibitor, in patients with advanced solid tumours with MET amplification

Eric Angevin,
Gianluca Spitaleri,
Jordi Rodon,
...
Alice Hervieu,
Karim Rihawi,
Filippo De Marinis

Published online: November 14, 2017

p131-139

Open Access

The use of sentinel lymph node biopsy in the treatment of breast ductal carcinoma in situ: A Danish population-based study

Emil Villiam Holm-Rasmussen,
Maj-Britt Jensen,
Eva Balslev,
Niels Kroman,
Tove Filtenborg Tvedskov

Published online: October 27, 2017

p1-9

Recurrence dynamics of breast cancer according to baseline body mass index

Elia Biganzoli,
Christine Desmedt,
Marco Fornili,
...
Christos Sotiriou,
Martine Piccart,
Romano Demicheli

Published online: October 30, 2017

p10-20

Is post-mastectomy radiation therapy contributive in pN0-1mi breast cancer patients? Results of a French multi-centric cohort

Violaine Forissier,
Agnès Tallet,
Monique Cohen,
...
Pierre Azuar,
Eric Lambaudie,
Gilles Houvenaeghel

Published online: November 03, 2017

p47-57

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer

R.A. Anderson,
J. Mansi,
R.E. Coleman,
D.J.A. Adamson,
R.C.F. Leonard

Published online: November 05, 2017

p58-64

Open Access

Prognostic value of tumour-infiltrating lymphocytes in small HER2-positive breast cancer

Carmen Criscitiello,
Vincenzo Bagnardi,
Giancarlo Pruneri,
...
Angela Esposito,
Nicole Rotmensz,
Giuseppe Curigliano

Published online: November 15, 2017

p164-171

Liver immunotolerance and hepatocellular carcinoma: Patho-physiological mechanisms and therapeutic perspectives

Gaël S. Roth,
Thomas Decaens

Published online: November 13, 2017

p101-112

Precision medicine for patients with advanced biliary tract cancers: An effective strategy within the prospective MOSCATO-01 trial

Loic Verlingue,
David Malka,
Adrien Allorant,
...
Michel Ducreux,
Jean-Charles Soria,
Antoine Hollebecque

Published online: November 13, 2017

p122-130

The association between health-related quality-of-life scores and clinical outcomes in metastatic castration-resistant prostate cancer patients: Exploratory analyses of AFFIRM and PREVAIL studies

Tomasz M. Beer,
Kurt Miller,
Bertrand Tombal,
...
Cristina Ivanescu,
Konstantina Skaltsa,
Shevani Naidoo

Published online: October 30, 2017

p21-29

Weekly cabazitaxel plus prednisone is effective and less toxic for ‘unfit’ metastatic castration-resistant prostate cancer: Phase II Spanish Oncology Genitourinary Group (SOGUG) trial

Miguel Ángel Climent,
Begoña Pérez-Valderrama,
Begoña Mellado,
...
Cristina Caballero,
María José Juan Fita,
Daniel Castellano

Published online: November 02, 2017

p30-37

Patterns of relapse in poor-prognosis germ-cell tumours in the GETUG 13 trial: Implications for assessment of brain metastases

Y. Loriot,
L. Pagliaro,
A. Fléchon,
...
G. Le Teuff,
S. Culine,
K. Fizazi

Published online: November 14, 2017

p140-146

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

Patrick Schöffski,
Agnieszka Wozniak,
Bernard Escudier,
...
Tiana Raveloarivahy,
Sandra Collette,
Laurence Albiges

Published online: November 14, 2017

p147-163

Outcomes from ovarian cancer screening in the PLCO trial: Histologic heterogeneity impacts detection, overdiagnosis and survival

Sarah M. Temkin,
Eric A. Miller,
Goli Samimi,
Christine D. Berg,
Paul Pinsky,
Lori Minasian

Published online: November 16, 2017

p182-188

European Research on Electrochemotherapy in Head and Neck Cancer (EURECA) project: Results from the treatment of mucosal cancers

Christina Caroline Plaschke,
Giulia Bertino,
James A. McCaul,
...
Francesca De Terlizzi,
Irene Wessel,
Julie Gehl

Published online: November 16, 2017

p172-181

Identification of single nucleotide polymorphisms of the PI3K-AKT-mTOR pathway as a risk factor of central nervous system metastasis in metastatic breast cancer

Emilie Le Rhun,
Nicolas Bertrand,
Aurélie Dumont,
...
Michael Weller,
Françoise Revillion,
Jacques Bonneterre

Published online: November 02, 2017

p189-198

COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss

Simon J. Crabb,
Karen Martin,
Julia Abab,
...
Christian Ottensmeier,
Robert Huddart,
Emma King

Published online: November 09, 2017

p75-83

Open Access

Site of childhood cancer care in the Netherlands

A.M.J. Reedijk,
M. van der Heiden-van der Loo,
O. Visser,
...
J.W.W. Coebergh,
L.C. Kremer,
R. Pieters

Published online: November 03, 2017

p38-46

Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon

Laura M. Legué,
Geert A. Simkens,
Geert-Jan M. Creemers,
Valery E.P.P. Lemmens,
Ignace H.J.T. de Hingh

Published online: November 10, 2017

p84-91

Risk of early-onset prostate cancer associated with occupation in the Nordic countries

Kathryn Hughes Barry,
Jan Ivar Martinsen,
Michael C.R. Alavanja,
...
Elisabete Weiderpass,
Sonja I. Berndt,
Eero Pukkala

Published online: November 10, 2017

p92-100

Time to diagnosis and treatment for cancer patients in the Netherlands: Room for improvement?

Charles (C.W.) Helsper,
Nicole (N.F.) van Erp,
Petra (P.H.M.) Peeters,
Niek (N.J.) de Wit

Published online: November 13, 2017

p113-121

Open Access

In the immuno-oncology era, is anti-PD-1 or anti-PD-L1 immunotherapy modifying the sensitivity to conventional cancer therapies?

Sandrine Aspeslagh,
Margarida Matias,
Virginia Palomar,
...
Emilie Lanoy,
Jean-Charles Soria,
Sophie Postel-Vinay

Published online: November 07, 2017

p65-74

Letter to the Editor regarding the paper by F. Cardoso et al. ‘European Breast Cancer Conference manifesto on breast centres/units’

Gianni Saguatti,
Carlo Naldoni,
Eva Benelli,
...
Fiammetta Querci,
Antonio Rizzo,
Lauro Bucchi

Published online: June 26, 2017

p199-200

Reply to letter from Suguatti et al.

Luigi Cataliotti,
Lorenza Marotti,
Marc Beishon,
...
Susan Knox,
Emiel Rutgers,
Fatima Cardoso

Published online: September 21, 2017

p201-202

Re: Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists

Peter C. Albertsen

Published online: September 22, 2017

p203

Response to letter – Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists

Lucie-Marie Scailteux

Published online: July 26, 2017

p204

Immune checkpoint inhibitor–associated CNS autoimmune disorder (ICICAD) following nivolumab treatment: A new entity of drug-induced autoimmune encephalitis?

Herwig Strik,
Ursula Keber,
Wasim Alhaj Hammoud,
...
Richard Dodel,
Axel Pagenstecher,
Andreas Neubauer

Published online: October 16, 2017

p205-208

Colchicine is an active treatment for everolimus-induced oral ulcers

Stanislas Ropert,
Romain Coriat,
Benjamin Verret,
...
Jean-Pierre Armand,
Angelo Paci,
Olivier Mir

Published online: October 13, 2017

p209-211

Immediate completion lymph node dissection in stage IIIA melanoma does not provide significant additional staging information beyond EORTC SN tumour burden criteria

Max F. Madu,
Viola Franke,
Maarten M. Bruin,
...
Michel W.J.M. Wouters,
Alexander C.J. van Akkooi,
Bart A. Van de Wiel

Published online: October 04, 2017

p212-215

Diarrhoea during checkpoint blockade, not always colitis

Josephine J. Koldenhof,
Karijn P.M. Suijkerbuijk

Published online: October 06, 2017

p216-218

Corrigendum to “Avoidable cancer cases in the Nordic countries – The impact of overweight and obesity” [Eur J Cancer 79 (2017) 106–118]

Therese M.-L. Andersson,
Elisabete Weiderpass,
Gerda Engholm,
...
Eero Pukkala,
Magnus Stenbeck,
Hans Storm

Published online: October 10, 2017

p219-220

‘Corrigendum to “Severe hepatitis under combined immunotherapy: Resolution under corticosteroids plus anti-thymocyte immunoglobulins” [Eur J Cancer 81 (August 2017) 203–205]’

Iris Spänkuch,
Maximilian Gassenmaier,
Ioanna Tampouri,
...
Andrea Forschner,
Claus Garbe,
Teresa Amaral

Published online: October 04, 2017

p221

December 2017

Drug development

Breast cancer

Gastrointestinal oncology

Urologic oncology

Gynecologic oncology

Head and neck oncology

Neuro-oncology

Quality of life

Epidemiology and prevention

Tumour immunology and immunotherapy

Correspondence

Corrigendum